Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Inflection Biosciences

Inflection Biosciences
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$814K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of small molecule therapeutics intended to help in the treatment of cancer. The company's small molecule therapeutics suggest potential application in a range of treatment for solid tumours and haematological malignancies, enabling health care providers to treat their patients in an enhanced way.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • Suite 15, Anglesea House
  • Carysfort Avenue, Blackrock County
  • Dublin
  • Ireland

+353 (01) 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Inflection Biosciences’s full profile, request a free trial.

Inflection Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 09-Mar-2015 $814K 00.000 Completed Pre-Clinical Trials
1. Seed Round 04-Jun-2013 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Inflection Biosciences Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cyteir Therapeutics Venture Capital-Backed Cambridge, MA 0 0000 00000000000 0000
0000000 0000000000 Venture Capital-Backed Diepenbeek, Belgium 0 000.00 00000000000 000.00
0000 0000000000 Venture Capital-Backed Beijing, China 0000 0000000000 0 0000
00000000 000000000 Private Equity-Backed San Francisco, CA 0000 0000000 0000 0000
00000000 Formerly VC-backed Florham Park, NJ 0 00000000
To view this company’s complete list of competitors, request access »

Inflection Biosciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Michael Smurfit Angel (individual) Minority 000 0000 000000 0
Enterprise Ireland Government Minority 000 0000 000000 0

Inflection Biosciences Executive Team (2)

Name Title Board
Seat
Contact
Info
Darren Cunningham Chief Executive Officer, Board Member & Co-Founder
Michael O'Neill Ph.D Director, Research & Development, Board Member & Co-Founder

Inflection Biosciences Board Members (6)

Name Representing Role Since Contact
Info
Conor Mallaghan Self Board Member 000 0000
Darren Cunningham Inflection Biosciences Chief Executive Officer, Board Member & Co-Founder 000 0000
John Lynch Inflection Biosciences Board Member 000 0000
John Scanlan Ph.D Inflection Biosciences Co-Founder & Board Member 000 0000
Michael O'Neill Ph.D Inflection Biosciences Director, Research & Development, Board Member & Co-Founder 000 0000
You’re viewing 5 of 6 board members. Get the full list »